Prostate cancer is the second leading cause of cancer death in men, and key determinants of its cellular phenotype include carcinogen defense (GSTP1), growth factor signaling pathways (NKX3.1, PTEN and p27) and AR60. Here, NKX3-1 is linked to prostate cancer.